APEXELL
Global leader in IPRs of Human Disease
APEXELL Co., Ltd
Global Leader in IPRs of Human Disease
Apexell specializes in intellectual property rights related to human diseases. It holds domestic and foreign patents for special substances related to anticancer drugs, and is leaping forward as a global company through R&D using experts and legal review of patents.
CLINICAL TRIALS
APEXELL has experienced several overseas clinical trials based on its new drug substance and has related know-how.
We are planning basic experiments on more than 100 types of cancer cells and clinical trials in Southeast Asia by utilizing new patents.
LICENSE OUT
APEXELL aims to license out by contacting global pharmaceutical companies based on basic cell experiments and overseas clinical trials. License out according to clinical trials that can be attempted by the company is proportional to more than 100 types of cancer diseases to which the new drug substance possessed by the company can be applied, and we aim to license out in the pre-clinical stage.
R&D
APEXELL intends to expand the range of diseases that can be used for its substances by establishing an affiliated research institute through an MOU and collaboration process with domestic university laboratories. After confirming effectiveness against various diseases including cancer, we plan to focus on patenting and commercialization.
MEDICAL OPERATION
APEXELL plans to operate specialized consignment operations for medical facilities and healing centers specializing in cancer management based on its anti-cancer drug and new drug-related technology. The facility plans medical services for the socially vulnerable by providing high-end services operated on a membership basis at home and abroad and in cooperation with a separate foundation under the Ministry of Patriots and Veterans Affairs.
IPRs
APEXELL is planning a process to expand the scope of its patent rights based on basic experiments on its new anti-cancer drug substances. Furthermore, new patents are planned for additional results obtained as a result of experiments, and at the same time, research results with potential in the bio and pharmaceutical fields are selected for conversion to intellectual property rights and commercialization.
DONATION FOUNDATION
Through an MOU with the Medical Foundation under the Ministry of Patriots and Veterans Affairs, we aim to provide quality medical services to the underprivileged in Korea. Furthermore, we focus on growing as a social enterprise by returning profits from our business to society.